(OCI) OCI - Overview
Stock: Ammonia, Methanol, Urea, Nitrogen, Melamine
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 122.26% |
| Yield on Cost 5y | 305.30% |
| Yield CAGR 5y | 11.99% |
| Payout Consistency | 85.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 39.5% |
| Relative Tail Risk | -23.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.30 |
| Alpha | -18.31 |
| Character TTM | |
|---|---|
| Beta | 0.105 |
| Beta Downside | -0.109 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.59% |
| CAGR/Max DD | -0.13 |
Description: OCI OCI January 15, 2026
OCI N.V. (AS: OCI) is a Dutch-based producer and distributor of hydrogen-derived and natural-gas-derived nitrogen chemicals, serving agricultural, transportation, and industrial markets across Europe, the Americas, the Middle East, Africa, Asia, and Oceania. The firm operates through three reporting segments-Methanol US, Methanol Europe, and Nitrogen Europe-and offers a portfolio that includes anhydrous ammonia, granular urea, urea-ammonium-nitrate solutions, calcium ammonium nitrate, ammonium sulphate, renewable-low-carbon ammonia, nitric acid, bio-methanol, methanol, melamine, CO₂, and diesel-exhaust fluid, plus ancillary storage and shipping services for ammonia at Rotterdam.
Key operational metrics: as of FY 2023, OCI reported an adjusted EBITDA margin of roughly 12 % and a total production capacity of ~5 Mt CO₂-equivalent of nitrogen products, with a 30 % share of its ammonia output sold into the EU market, where tightening nitrogen-emission standards are driving demand for low-carbon fertilizers. The company’s exposure to natural-gas price volatility remains a material risk, but its recent investments in green-hydrogen and bio-methanol projects aim to decouple earnings from fossil-fuel input costs and align with the EU’s Green Deal incentives.
For a deeper quantitative assessment, see the OCI page on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 5.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.07 > 0.02 and ΔFCF/TA -8.07 > 1.0 |
| NWC/Revenue: 188.4% < 20% (prev 77.06%; Δ 111.3% < -1%) |
| CFO/TA -0.12 > 3% & CFO -407.4m > Net Income 5.31b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (210.9m) vs 12m ago -0.06% < -2% |
| Gross Margin: -19.77% > 18% (prev 0.08%; Δ -1986 % > 0.5%) |
| Asset Turnover: 8.53% > 50% (prev 28.63%; Δ -20.10% > 0%) |
| Interest Coverage Ratio: -2.43 > 6 (EBITDA TTM -212.0m / Interest Expense TTM 107.4m) |
Altman Z'' 2.22
| A: 0.28 (Total Current Assets 2.55b - Total Current Liabilities 1.54b) / Total Assets 3.54b |
| B: 0.14 (Retained Earnings 479.0m / Total Assets 3.54b) |
| C: -0.04 (EBIT TTM -260.7m / Avg Total Assets 6.26b) |
| D: 0.18 (Book Value of Equity 303.9m / Total Liabilities 1.67b) |
| Altman-Z'' Score: 2.22 = BBB |
Beneish M 1.00
| DSRI: 8.74 (Receivables 693.3m/382.1m, Revenue 534.1m/2.57b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 2.37 (AQ_t 0.11 / AQ_t-1 0.05) |
| SGI: 0.21 (Revenue 534.1m / 2.57b) |
| TATA: 1.62 (NI 5.31b - CFO -407.4m) / TA 3.54b) |
| Beneish M-Score: 5.25 (Cap -4..+1) = D |
What is the price of OCI shares?
Over the past week, the price has changed by +9.08%, over one month by +20.52%, over three months by +11.94% and over the past year by -11.43%.
Is OCI a buy, sell or hold?
What are the forecasts/targets for the OCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.8 | 57.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 11.4 | 210.3% |
OCI Fundamental Data Overview February 03, 2026
Market Cap USD = 899.0m (761.8m EUR * 1.1801 EUR.USD)
P/E Forward = 30.2115
P/S = 0.7005
P/B = 0.4452
Revenue TTM = 534.1m USD
EBIT TTM = -260.7m USD
EBITDA TTM = -212.0m USD
Long Term Debt = 114.7m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 755.8m USD (from shortTermDebt, last quarter)
Debt = 853.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -915.7m USD (from netDebt column, last quarter)
Enterprise Value = -16.7m USD (899.0m + Debt 853.7m - CCE 1.77b)
Interest Coverage Ratio = -2.43 (Ebit TTM -260.7m / Interest Expense TTM 107.4m)
EV/FCF = 0.06x (Enterprise Value -16.7m / FCF TTM -264.2m)
FCF Yield = 1583 % (FCF TTM -264.2m / Enterprise Value -16.7m)
FCF Margin = -49.47% (FCF TTM -264.2m / Revenue TTM 534.1m)
Net Margin = 994.6% (Net Income TTM 5.31b / Revenue TTM 534.1m)
Gross Margin = -19.77% ((Revenue TTM 534.1m - Cost of Revenue TTM 639.7m) / Revenue TTM)
Gross Margin QoQ = -5.66% (prev -5.66%)
Tobins Q-Ratio = -0.00 (set to none) (Enterprise Value -16.7m / Total Assets 3.54b)
Interest Expense / Debt = 6.29% (Interest Expense 53.7m / Debt 853.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = -206.0m (EBIT -260.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.65 (Total Current Assets 2.55b / Total Current Liabilities 1.54b)
Debt / Equity = 0.46 (Debt 853.7m / totalStockholderEquity, last quarter 1.86b)
Debt / EBITDA = 4.32 (negative EBITDA) (Net Debt -915.7m / EBITDA -212.0m)
Debt / FCF = 3.47 (negative FCF - burning cash) (Net Debt -915.7m / FCF TTM -264.2m)
Total Stockholder Equity = 2.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 84.87% (Net Income 5.31b / Total Assets 3.54b)
RoE = 258.7% (Net Income TTM 5.31b / Total Stockholder Equity 2.05b)
RoCE = -12.03% (EBIT -260.7m / Capital Employed (Equity 2.05b + L.T.Debt 114.7m))
RoIC = -7.91% (negative operating profit) (NOPAT -206.0m / Invested Capital 2.60b)
WACC = 5.65% (E(899.0m)/V(1.75b) * Re(6.30%) + D(853.7m)/V(1.75b) * Rd(6.29%) * (1-Tc(0.21)))
Discount Rate = 6.30% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.01%
Fair Price DCF = unknown (Cash Flow -264.2m)
EPS Correlation: -70.57 | EPS CAGR: -65.41% | SUE: -3.96 | # QB: 0
Revenue Correlation: -56.59 | Revenue CAGR: -36.29% | SUE: 0.28 | # QB: 0
EPS next Year (2026-12-31): EPS=0.05 | Chg30d=-0.046 | Revisions Net=-2 | Growth EPS=+168.2% | Growth Revenue=-0.7%